| |
| |
|
| Insider
Information: |
Bjerkholt Eric |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
574,968 |
|
|
Indirect Shares
|
83,827 |
|
|
| Direct
Value |
$683,647 |
|
|
|
Indirect Value
|
$51,637 |
|
|
| Total
Shares |
658,795 |
|
|
| Total
Value |
$735,284 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
4
|
|
Stock
price went up :
|
6
|
4
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
6.0
|
4.0
|
| Percentage
Gain/Loss : |
 47.4%
|
276.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Viracta Therapeutics Ord Shs |
VIRX |
EVP, CFO & Corp. Secre... |
2016-02-29 |
100,922 |
2016-02-29 |
83,827 |
Premium* |
|
|
Microbot Medical Inc |
MBOT |
Director |
2016-01-01 |
273,759 |
2010-03-01 |
0 |
Premium* |
|
|
Corium International, Inc. |
CORI |
Director |
2016-05-18 |
0 |
2018-11-27 |
0 |
Premium* |
|
|
Aimmune Therapeutics, Inc. |
AIMT |
Chief Financial Officer |
2020-10-13 |
0 |
2017-05-12 |
0 |
Premium* |
|
|
Cerus Corp |
CERS |
Director |
2024-06-05 |
182,133 |
2019-10-04 |
0 |
Premium* |
|
|
Chinook Therapeutics Inc |
KDNY |
Chief Financial Officer |
2023-08-11 |
0 |
|
0 |
Premium* |
|
|
Calcimedica Ord Shs |
CALC |
Director |
2023-05-31 |
3,684 |
2023-03-23 |
0 |
Premium* |
|
|
Mirum Pharmaceuticals, Inc. |
MIRM |
|
2024-05-10 |
14,470 |
2023-09-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
83 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KDNY |
Chinook Therapeutics Inc |
Chief Financial OfficerOfficer |
• – – |
2020-11-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
% |
|
| MBOT |
Microbot Medical Inc |
Director |
– • – |
2010-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Sr. VP, CFO & Corp. Secretary |
• – – |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
99,940 |
338,183 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Sr. VP, CFO & Corp. Secretary |
• – – |
2010-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
31,546 |
37,641 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Sr. VP, CFO & Corp. Secretary |
• – – |
2011-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
11,383 |
15,728 |
0 |
- |
|
| MBOT |
Microbot Medical Inc |
Director |
– • – |
2011-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
20,000 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
EVP, CFO & Corp. Secretary |
• – – |
2012-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
17,349 |
32,222 |
0 |
- |
|
| MBOT |
Microbot Medical Inc |
Director |
– • – |
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
3,000 |
0 |
- |
|
| MBOT |
Microbot Medical Inc |
Director |
– • – |
2012-04-18 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
12,000 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
EVP, CFO & Corp. Secretary |
• – – |
2013-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,088 |
36,593 |
0 |
- |
|
| MBOT |
Microbot Medical Inc |
Director |
– • – |
2013-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
22,000 |
0 |
- |
|
| MBOT |
Microbot Medical Inc |
Director |
– • – |
2014-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
47,164 |
69,164 |
0 |
- |
|
| MBOT |
Microbot Medical Inc |
Director |
– • – |
2015-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
58,253 |
127,417 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
EVP, CFO & Corp. Secretary |
• – – |
2015-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
17,642 |
57,636 |
0 |
- |
|
| MBOT |
Microbot Medical Inc |
Director |
– • – |
2016-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
146,342 |
273,759 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
EVP, CFO & Corp. Secretary |
• – – |
2016-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
135,913 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2018-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
9,375 |
17,500 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2019-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
13,125 |
32,857 |
0 |
- |
|
| CERS |
Cerus Corp |
Director |
– • – |
2019-10-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,282 |
4,282 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,375 |
42,949 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,420 |
45,387 |
0 |
- |
|
| CERS |
Cerus Corp |
Director |
– • – |
2020-10-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,281 |
28,563 |
0 |
- |
|
| CERS |
Cerus Corp |
Director |
– • – |
2021-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,228 |
41,791 |
0 |
- |
|
| CERS |
Cerus Corp |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
14,888 |
56,679 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,414 |
26,414 |
0 |
- |
|
83 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
